FDA Import Refusal 799-0975462-2/11/1 — Bausch Health Companies Inc.
The FDA refused shipment 799-0975462-2/11/1 from Bausch Health Companies Inc. (Canada) on May 28, 2019. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 28, 2019
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62OCB24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75